201 related articles for article (PubMed ID: 18366728)
21. The Fibronectin Expression Determines the Distinct Progressions of Malignant Gliomas via Transforming Growth Factor-Beta Pathway.
Chen CW; Yang CH; Lin YH; Hou YC; Cheng TJ; Chang ST; Huang YH; Chung ST; Chio CC; Shan YS; Cheng HC; Chang WT
Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33917452
[TBL] [Abstract][Full Text] [Related]
22. Investigating Trans-differentiation of Glioblastoma Cells in an
Hatlen RR; Rajagopalan P
ACS Biomater Sci Eng; 2023 Jun; 9(6):3445-3461. PubMed ID: 37129167
[TBL] [Abstract][Full Text] [Related]
23. Combined elevation of TRIB2 and MAP3K1 indicates poor prognosis and chemoresistance to temozolomide in glioblastoma.
Wang J; Zuo J; Wahafu A; Wang MD; Li RC; Xie WF
CNS Neurosci Ther; 2020 Mar; 26(3):297-308. PubMed ID: 31318172
[TBL] [Abstract][Full Text] [Related]
24. Musashi-1 Enhances Glioblastoma Migration by Promoting ICAM1 Translation.
Lin JC; Tsai JT; Chao TY; Ma HI; Liu WH
Neoplasia; 2019 May; 21(5):459-468. PubMed ID: 30959276
[TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of MGMT methylation and expression of MGMT, P53, EGFR, MDM2 and PTEN in glioblastoma multiforme.
Limam S; Missaoui N; Abdessayed N; Mestiri S; Selmi B; Mokni M; Yacoubi MT
Ann Biol Clin (Paris); 2019 Jun; 77(3):307-317. PubMed ID: 31131831
[TBL] [Abstract][Full Text] [Related]
26. High expression of RFX4 is associated with tumor progression and poor prognosis in patients with glioblastoma.
Jeong HY; Kim HJ; Kim CE; Lee S; Choi MC; Kim SH
Int J Neurosci; 2021 Jan; 131(1):7-14. PubMed ID: 32075484
[No Abstract] [Full Text] [Related]
27. Ecotropic viral integration site 1 regulates EGFR transcription in glioblastoma cells.
Mizuguchi A; Yamashita S; Yokogami K; Morishita K; Takeshima H
J Neurooncol; 2019 Nov; 145(2):223-231. PubMed ID: 31617054
[TBL] [Abstract][Full Text] [Related]
28. Analysis of the cancer genome atlas (TCGA) database identifies an inverse relationship between interleukin-13 receptor α1 and α2 gene expression and poor prognosis and drug resistance in subjects with glioblastoma multiforme.
Han J; Puri RK
J Neurooncol; 2018 Feb; 136(3):463-474. PubMed ID: 29168083
[TBL] [Abstract][Full Text] [Related]
29. Effect of the JAK2/STAT3 inhibitor SAR317461 on human glioblastoma tumorspheres.
Mukthavaram R; Ouyang X; Saklecha R; Jiang P; Nomura N; Pingle SC; Guo F; Makale M; Kesari S
J Transl Med; 2015 Aug; 13():269. PubMed ID: 26283544
[TBL] [Abstract][Full Text] [Related]
30. miR‑378a‑3p inhibits cellular proliferation and migration in glioblastoma multiforme by targeting tetraspanin 17.
Guo XB; Zhang XC; Chen P; Ma LM; Shen ZQ
Oncol Rep; 2019 Nov; 42(5):1957-1971. PubMed ID: 31432186
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of FoxO3a is associated with glioblastoma progression and predicts poor patient prognosis.
Qian Z; Ren L; Wu D; Yang X; Zhou Z; Nie Q; Jiang G; Xue S; Weng W; Qiu Y; Lin Y
Int J Cancer; 2017 Jun; 140(12):2792-2804. PubMed ID: 28295288
[TBL] [Abstract][Full Text] [Related]
32. Hypoxia-regulated protein expression, patient characteristics, and preoperative imaging as predictors of survival in adults with glioblastoma multiforme.
Flynn JR; Wang L; Gillespie DL; Stoddard GJ; Reid JK; Owens J; Ellsworth GB; Salzman KL; Kinney AY; Jensen RL
Cancer; 2008 Sep; 113(5):1032-42. PubMed ID: 18618497
[TBL] [Abstract][Full Text] [Related]
33. The relationship of erythropoietin receptor expression and prognosis in glioblastoma multiforme patients.
Cevik S; Kitis S; Evran S; Akkaya E; Tosuner Z; Hanimoglu H
Niger J Clin Pract; 2018 Apr; 21(4):502-506. PubMed ID: 29607865
[TBL] [Abstract][Full Text] [Related]
34. Platelets from glioblastoma patients promote angiogenesis of tumor endothelial cells and exhibit increased VEGF content and release.
Di Vito C; Navone SE; Marfia G; Abdel Hadi L; Mancuso ME; Pecci A; Crisà FM; Berno V; Rampini P; Campanella R; Riboni L
Platelets; 2017 Sep; 28(6):585-594. PubMed ID: 27897101
[TBL] [Abstract][Full Text] [Related]
35. γ-Glutamyl transferase 7 is a novel regulator of glioblastoma growth.
Bui TT; Nitta RT; Kahn SA; Razavi SM; Agarwal M; Aujla P; Gholamin S; Recht L; Li G
BMC Cancer; 2015 Apr; 15():225. PubMed ID: 25884624
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA‑518b functions as a tumor suppressor in glioblastoma by targeting PDGFRB.
Xu X; Zhang F; Chen X; Ying Q
Mol Med Rep; 2017 Oct; 16(4):5326-5332. PubMed ID: 28849154
[TBL] [Abstract][Full Text] [Related]
37. Loss of EphA7 Expression in Basal Cell Carcinoma by Hypermethylation of CpG Islands in the Promoter Region.
Liu J; Yu N; Feng X; He Y; Lv K; Zhu H; Wang J
Anal Cell Pathol (Amst); 2022; 2022():4220786. PubMed ID: 35103233
[TBL] [Abstract][Full Text] [Related]
38. Chemoradiotherapy Increases Intratumor Heterogeneity of HPSE Expression in the Relapsed Glioblastoma Tumors.
Suhovskih AV; Kazanskaya GM; Volkov AM; Tsidulko AY; Aidagulova SV; Grigorieva EV
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32075104
[TBL] [Abstract][Full Text] [Related]
39. Loss of cytoskeleton protein ADD3 promotes tumor growth and angiogenesis in glioblastoma multiforme.
Kiang KM; Zhang P; Li N; Zhu Z; Jin L; Leung GK
Cancer Lett; 2020 Apr; 474():118-126. PubMed ID: 31958485
[TBL] [Abstract][Full Text] [Related]
40. Tumor-Educated Platelets and Angiogenesis in Glioblastoma: Another Brick in the Wall for Novel Prognostic and Targetable Biomarkers, Changing the Vision from a Localized Tumor to a Systemic Pathology.
Campanella R; Guarnaccia L; Cordiglieri C; Trombetta E; Caroli M; Carrabba G; La Verde N; Rampini P; Gaudino C; Costa A; Luzzi S; Mantovani G; Locatelli M; Riboni L; Navone SE; Marfia G
Cells; 2020 Jan; 9(2):. PubMed ID: 31991805
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
